Trials / Terminated
TerminatedNCT01183442
Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia
Effects of Vitamin D Supplementation in Coronary Artery Disease Patients With Postchallenge Hyperglycemia and Vitamin D Deficiency on Endothelial Function and Insulin Sensitivity
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main aim of the investigation is to clarify, whether vitamin D supplementation in coronary artery disease patients with vitamin D deficiency and postchallenge hyperglycemia has an impact on endothelial dysfunction and parameters of insulin sensitivity and beta-cell function.
Detailed description
An improvement of endothelial dysfunction as a cardiovascular surrogate parameter could be translated in a reduced risk for future cardiovascular events, which is of major interest, since patients with postchallenge hyperglycemia face a significantly higher cardiovascular risk than patients with normal glucose tolerance. Furthermore an improvement in insulin sensitivity and/or beta-cell function would identify vitamin D as an important strategy for the prevention of type 2 diabetes. In consideration of the rapidly increasing prevalence of diabetes and the failure of current prevention strategies this could be an important, safe and cheap way to support ongoing lifestyle modifying programs. Our study of course investigates surrogate cardiovascular and insulin sensitivity parameters. Assuming a beneficial effect of vitamin D in our study, this concept would have to be proven in further large outcome as well as diabetes prevention trials.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vitamin D | orally administered 2800 IU of vitamin D or placebo daily |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2010-08-17
- Last updated
- 2015-04-17
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01183442. Inclusion in this directory is not an endorsement.